Identification of alternative mechanisms of resistance to FGFR inhibitor treatment in FGFR1-amplified large cell compared to FGFR1-amplified small cell lung cancer models

被引：1
|
作者：
Jovcheva, Eleonora [1 ]
Ogata, Souichi [1 ]
Van De Ven, Kelly [1 ]
Paulussen, Caroline [1 ]
Van de Weyer, Inez [1 ]
Wolf, Hans D. [1 ]
Ceulemans, Hugo [1 ]
McClue, Steve [2 ]
Vialard, Jorge [1 ]
Perera, Timothy [1 ]
机构：
[1] Janssen, Beerse, Belgium
[2] Janssen, High Wycombe, Bucks, England
来源：
CANCER RESEARCH | 2014年 / 74卷 / 19期
关键词：
D O I：
10.1158/1538-7445.AM2014-LB-329
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
329
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Nuclear FGFR1 interaction with estrogen receptor (ER) α is associated with resistance to endocrine therapy in ER+/FGFR1-amplified breast cancer
    Formisano, L.
    Young, C. D.
    Bhola, N. E.
    Bulen, B.
    Estrada, V. M.
    Wagle, N.
    Van Allen, E.
    Brewer, M. L. Red
    Jansen, V. M.
    Guerrero, A. L.
    Giltnane, J. M.
    Strcker, T.
    Arteaga, C. L.
    CANCER RESEARCH, 2016, 76
  • [32] Co-active receptor tyrosine kinases mitigate the effect of FGFR inhibitors in FGFR1-amplified lung cancers with low FGFR1 protein expression
    H Kotani
    H Ebi
    H Kitai
    S Nanjo
    K Kita
    T G Huynh
    A Ooi
    A C Faber
    M Mino-Kenudson
    S Yano
    Oncogene, 2016, 35 : 3587 - 3597
  • [33] Translating the therapeutic potential of AZD4547 in FGFR1-amplified non-small cell lung cancer through the use of primary lung explant models
    Zhang, Jingchuan
    Zhang, Lin
    Su, Xinying
    Li, Ming
    Fan, ShuQiong
    Yin, XiaoLu
    Xu, YanPing
    Liu, Kunji
    Dong, Zhengwei
    Zhu, Guanshan
    Kilgour, Elaine
    Smith, Paul D.
    Brooks, A. Nigel
    Gavine, Paul R.
    CANCER RESEARCH, 2012, 72
  • [34] FGFR1 signaling modulates estrogen-independent ER transcriptional activity in ER+/FGFR1-amplified breast cancer cells
    Servetto, Alberto
    Formisano, Luigi
    Kollipara, Rahul
    Sudhan, Dhivya R.
    Lee, Kyung-min
    Chatterjee, Sumanta
    Hanker, Ariella B.
    Mendiratta, Saurabh
    Kittler, Ralf
    Arteaga, Carlos L.
    CANCER RESEARCH, 2019, 79 (13)
  • [35] Functional Screens to Identify Mechanisms of Resistance to FGFR Inhibitors in FGFR Amplified and Mutated Cell Lines
    Abreu, M. Herrera
    Garcia-Murilla, I.
    Pearson, A.
    Shnyder, S.
    Knowles, M.
    Turner, N. C.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : 50 - 50
  • [36] Translating the Therapeutic Potential of AZD4547 in FGFR1-Amplified Non-Small Cell Lung Cancer through the Use of Patient-Derived Tumor Xenograft Models
    Zhang, Jingchuan
    Zhang, Lin
    Su, Xinying
    Li, Ming
    Xie, Liang
    Malchers, Florian
    Fan, ShuQiong
    Yin, XiaoLu
    Xu, YanPing
    Liu, Kunji
    Dong, Zhengwei
    Zhu, Guanshan
    Qian, Ziliang
    Tang, Lili
    Zhan, Ping
    Ji, Qunsheng
    Kilgour, Elaine
    Smith, Paul D.
    Brooks, A. Nigel
    Thomas, Roman K.
    Gavine, Paul R.
    CLINICAL CANCER RESEARCH, 2012, 18 (24) : 6658 - 6667
  • [37] FGFR1-ERK1/2-SOX2 axis promotes cell proliferation, epithelial-mesenchymal transition, and metastasis in FGFR1-amplified lung cancer (vol 15, pg 732, 2020)
    Wang, Kaixuan
    Ji, Wenxiang
    Yu, Yongfeng
    Li, Ziming
    Niu, Xiaomin
    Xia, Weiliang
    Lu, Shun
    ONCOGENE, 2020, 39 (42) : 6619 - 6620
  • [38] A multicenter, open-label phase II trial of dovitinib, a fibroblast growth factor receptor 1 (FGFR1) inhibitor, in FGFR1-amplified and nonamplified metastatic breast cancer (BC).
    Andre, F.
    Bachelot, T. D.
    Campone, M.
    Dalenc, F.
    Perez-Garcia, J. M.
    Hurvitz, S. A.
    Turner, N. C.
    Rugo, H. S.
    Baselga, J.
    Zhang, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (27)
  • [39] An open-label phase IB study to evaluate GSK3052230 in combination with paclitaxel and carboplatin, or docetaxel, in FGFR1-amplified non-small cell lung cancer
    Morgensztern, Daniel
    Karaseva, Nina
    Felip, Enriqueta
    Delgado, Ignacio
    Burdaeva, Olga
    Domine, Manuel
    Lara, Primo
    Paik, Paul K.
    Lassen, Ulrik
    Orlov, Sergey
    Trigo, Jose
    Shomova, Marina
    Baker-Neblett, Katherine
    Vasquez, James
    Wang, Xiaowei
    Yan, Li
    Mitrica, Ionel
    DeYoung, M. Phillip
    Garrido, Pilar
    LUNG CANCER, 2019, 136 : 74 - 79
  • [40] Cell-Autonomous and Non-Cell-Autonomous Mechanisms of Transformation by Amplified FGFR1 in Lung Cancer
    Malchers, Florian
    Dietlein, Felix
    Schottle, Jakob
    Lu, Xin
    Nogova, Lucia
    Albus, Kerstin
    Fernandez-Cuesta, Lynnette
    Heuckmann, Johannes M.
    Gautschi, Oliver
    Diebold, Joachim
    Plenker, Dennis
    Gardizi, Masyar
    Er, Matthias Scheffl
    Bos, Marc
    Seidel, Danila
    Leenders, Frauke
    Richters, Andre
    Peifer, Martin
    Florin, Alexandra
    Mainkar, Prathama S.
    Karre, Nagaraju
    Chandrasekhar, Srivari
    George, Julie
    Silling, Steffi
    Rauh, Daniel
    Zander, Thomas
    Ullrich, Roland T.
    Reinhardt, H. Christian
    Ringeisen, Francois
    Buettner, Reinhard
    Heukamp, Lukas C.
    Wolf, Juergen
    Thomas, Roman K.
    CANCER DISCOVERY, 2014, 4 (02) : 246 - 257
12345